$1.14
0.09[8.57%]
Last update: 7:59PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$1.14
0[0.00%]
| Open1.060 | Close0.995 |
| Vol / Avg.46.054K / 188.494K | Mkt Cap26.944M |
| Day Range0.980 - 1.070 | 52 Wk Range0.500 - 1.680 |
Kazia Therapeutics Stock (NASDAQ:KZIA), Key Statistics
Kazia Therapeutics Stock (NASDAQ: KZIA) analysis, key statistics.
Valuation Measures
Enterprise Value
22.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
3.22
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-68.37%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.33
Tangible Book value per share
-0.14
Total Liabilities (Quarterly)
16M
Total Assets
28.1M
Total Liabilities
16M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Kazia Therapeutics Stock (NASDAQ:KZIA), Key Statistics
Kazia Therapeutics Stock (NASDAQ: KZIA) analysis, key statistics.
Valuation Measures
Enterprise Value
22.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
3.22
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-68.37%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.33
Tangible Book value per share
-0.14
Total Liabilities (Quarterly)
16M
Total Assets
28.1M
Total Liabilities
16M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Kazia Therapeutics Stock (NASDAQ:KZIA), Key Statistics
Kazia Therapeutics Stock (NASDAQ: KZIA) analysis, key statistics.
Valuation Measures
Enterprise Value
22.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
3.22
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-68.37%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.33
Tangible Book value per share
-0.14
Total Liabilities (Quarterly)
16M
Total Assets
28.1M
Total Liabilities
16M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Kazia Therapeutics Stock (NASDAQ:KZIA), Key Statistics
Kazia Therapeutics Stock (NASDAQ: KZIA) analysis, key statistics.
Valuation Measures
Enterprise Value
22.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
3.22
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-68.37%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.33
Tangible Book value per share
-0.14
Total Liabilities (Quarterly)
16M
Total Assets
28.1M
Total Liabilities
16M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Kazia Therapeutics Stock (NASDAQ:KZIA), Key Statistics
Kazia Therapeutics Stock (NASDAQ: KZIA) analysis, key statistics.
Valuation Measures
Enterprise Value
22.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
3.22
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-68.37%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.33
Tangible Book value per share
-0.14
Total Liabilities (Quarterly)
16M
Total Assets
28.1M
Total Liabilities
16M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Kazia Therapeutics Stock (NASDAQ:KZIA), Key Statistics
Kazia Therapeutics Stock (NASDAQ: KZIA) analysis, key statistics.
Valuation Measures
Enterprise Value
22.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
3.22
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-68.37%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.33
Tangible Book value per share
-0.14
Total Liabilities (Quarterly)
16M
Total Assets
28.1M
Total Liabilities
16M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Kazia Therapeutics Stock (NASDAQ:KZIA), Key Statistics
Kazia Therapeutics Stock (NASDAQ: KZIA) analysis, key statistics.
Valuation Measures
Enterprise Value
22.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
3.22
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-68.37%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.33
Tangible Book value per share
-0.14
Total Liabilities (Quarterly)
16M
Total Assets
28.1M
Total Liabilities
16M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Kazia Therapeutics Stock (NASDAQ:KZIA), Key Statistics
Kazia Therapeutics Stock (NASDAQ: KZIA) analysis, key statistics.
Valuation Measures
Enterprise Value
22.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
3.22
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-68.37%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.33
Tangible Book value per share
-0.14
Total Liabilities (Quarterly)
16M
Total Assets
28.1M
Total Liabilities
16M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
Kazia Therapeutics Stock (NASDAQ:KZIA), Key Statistics
Kazia Therapeutics Stock (NASDAQ: KZIA) analysis, key statistics.
Valuation Measures
Enterprise Value
22.8M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
3.22
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-68.37%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
0.33
Tangible Book value per share
-0.14
Total Liabilities (Quarterly)
16M
Total Assets
28.1M
Total Liabilities
16M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -